| produktnamn |
ESS 031 |
| Också känd som |
ESS-031 Peptide |
| Utseende |
Freeze-Dried White Powder |
| Standard |
Farmaceutisk |
| Renhet |
99% |
| Application Type |
Injection |
| Supplying Form |
Lyophilized Powder In Vials / Pure Raw Powder No Vial |
ESS-031 is a soluble fusion protein that has been shown to increase muscle mass and strength in the study. ESS-031 is being studied as a metabolic disease, children with kidney tumors, cardiovascular abnormalities, age-related muscle loss and cancer treatment-related muscle loss and neuromuscular disease treatment. ESS-031 is a biotherapeutic agent based on activin receptor type IIB (ActRIIB). The molecule binds to ActRIIB receptors to inhibit signaling and increases muscle mass and intensity. ESS-031 is a recombinant fusion protein synthesized by fusion of standard antibodies and partial ActRIIB receptors. Recombinant fusion proteins eliminate myogenic inhibin and other biomolecules that limit muscle strength or growth.
ESS-031 is a protein that regulates muscle growth in the TGF-β superfamily. ESS-031 acts on the molecular switches of these molecules and promotes muscle growth. In the experimental study, ESS-031 promoted muscle growth and inhibited ActRIIB receptor signaling. In preclinical studies, administration of ACE-031 for two weeks increased skeletal muscle density, decreased leptin levels, and increased adiponectin.
Some bodybuilders use ACE-031 to promote muscle growth and improve lean muscle. ESS-031 No serious adverse events. Most common adverse events are mild and tolerant. The polypeptide contains 368 amino acid molecules that form a very large polypeptide complex. Muscle growth is regulated by the production of amino acids, and the TGFβ protein superfamily is primarily a regulator, and as mentioned above, the switch mechanism is essential for muscle production. When the ActRIIB receptor interacts with GDF-8, it emits an opening signal that promotes muscle growth.
Even a small dose of 1 mg of ACE-031 can produce a substantial effect. Athletes taking 1 mg of ACE-031 per week during the 3-4 week, almost immediately increase muscle stiffness and muscle mass and strength of the rapid growth, even more than the most effective iron core volume of synthetic androgen steroids!
Another dose option was to increase the dose of 100 mcg per week from the ACE-031 dose of 200 mcg per day, while the treatment cycle should last for another 3-4 weeks.
Once the ACE-031 cycle is complete, it is recommended to take a break in two weeks.
